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ABSTRACT Neurodegeneration observed in Alzheimer disease (AD) is believed to be related to the toxicity from reactive oxygen
species (ROS) produced in the brain by the amyloid-b (Ab) protein bound primarily to copper ions. The evidence for an oxidative
stress role of Ab-Cu redox chemistry is still incomplete. Details of the copper binding site in Abmay be critical to the etiology of AD.
Here we present the structure determined by combining x-ray absorption spectroscopy (XAS) and density functional theory analysis
of Ab peptides complexed with Cu21 in solution under a range of buffer conditions. Phosphate-buffered saline buffer salt (NaCl)
concentration does not affect the high-afﬁnity copper binding mode but alters the second coordination sphere. The XAS spectra for
truncated and full-length Ab-Cu21 peptides are similar. The novel distorted six-coordinated (3N3O) geometry around copper in the
Ab-Cu21 complexes include three histidines: glutamic, or/and aspartic acid, and axial water. The structure of the high-afﬁnity Cu21
binding site is consistent with the hypothesis that the redox activity of themetal ion bound toAb can lead to the formation of dityrosine-
linked dimers found in AD.
INTRODUCTION
Alzheimer disease (AD) is a progressive neurodegenerative
disorder characterized by the presence of misfolded protein
depositions or amyloid plaques. The major constituent of AD
plaques is the amyloid-b peptide (Ab, up to 42 amino acids:
D1AEFRH6DSGY10E11VH13H14QK16LVFFAEDVGSNK28-
GAIIGLM35VGGVVIA42), which is cleaved from the mem-
brane-bound amyloid precursor protein via the b/g-secretase
pathway. Current consensus in AD research is that soluble Ab
oligomer intermediates rather than the plaque burden (1,2) are
the major contributors to Ab-mediated neurodegeneration. In
vitro Ab binds to Cu, Zn, and Fe with relatively high afﬁnity,
and elevated levels of these metals are found in AD amyloid
deposits (3,4). Metals can mediate oligomerization of Ab, and
the neurotoxicity of Ab has been related to its ability to form
complexes with redox-susceptible ions, Cu21 in particular (4).
The Ab-Cu21 complexes can be involved in extensive redox
chemical reactions that produce H2O2 and other reactive
oxygen species (ROS) from molecular oxygen (4,5). Sum-
marizing these studies (6), it is evident ﬁrst that the monomeric
soluble full-length Ab140/42 peptides and truncated Ab128
and Ab116 peptides bind the Cu
21 ion at a high-afﬁnity site
with the same coordination environment in a 1:1 stoichio-
metric ratio (7–12). Residues 1–17 are unstructured and do not
participate in the b-sheet packing (13,14). The Cu21 coordi-
nation by the hydrophobic C-terminal residues (aa 29–42), in
particular by Met-35, was ruled out (15), and the voltammetric
studies of three Cu21 complexes with Ab116, Ab128, and
Ab142 were similar (9,16). Second, recent studies indicate the
involvement of the three histidines His-6, His-13, and His-14
(8,11,17–19). The fourth ligand is most likely an oxygen atom
donor (20). Some choices for the fourth ligand included
Tyr10 (20–22), the N-terminal nitrogen, or Asp-1 carboxylate
(7,8,17,19), or other carboxylate side chains. The Glu-11 res-
idueprovides the carboxylate side chainwhenZn21 is bound to
human Ab1–16 (23) and Ab1–28 (24), and there is evidence that
the Asp-1 carboxylate side chain interacts via hydrogen
bonding to an axial water from the ﬁrst coordination shell of
Cu21 (25). Marked 1H relaxation enhancements were also
noticeable for the Glu-11 (Fig. 2 in the study by Gaggelli et al.
(25)). Recent extendedx-ray absorption ﬁne structure (EXAFS)
analyses of the Ab1-40-Cu
21 (26) and Ab1-16-Cu
21 (27) com-
plexes with 1:1 metal/peptide ratio suggested that Cu21 is
pentacoordinated to three nitrogen atoms (from His-6, His-13,
and His-14) and two oxygen atoms, with one from Tyr-10 and
the other one from either a water molecule or an amino acid
other than the bound histidine and tyrosine residues. Con-
versely, there is a compelling evidence that tyrosine (Tyr-10) is
not the oxygen atom donor (7,8,11,18,19). Furthermore, in an
analysis (28) ofmetal binding sites inmetalloproteins, aspartate
and glutamate were often found in the coordination sphere of
Cu or Zn, whereas tyrosine binding was rare.
Native, full-length Ab peptide forms aggregates with
metastable and polydisperse structures, whereas truncated
Ab116 peptide does not, which is relatively hydrophilic and
more soluble compared to the full-length peptide in the range
of conditions compared to the full-length peptide. The dis-
crepancy in metal binding geometry in Ab peptides has been
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attributed to the differences in preparation of peptide, buffer
conditions, pH, and in the mode of presentation of Cu21 to
the Ab peptide (10,11,29). Some studies (30,31) showed that
NaCl presence in buffer greatly encourages metal-mediated
oligomerization of Ab and may alter the metal binding site.
The structural diversity in the aggregated structures and
possibly in metal binding geometry can be interpreted in
terms of the difference in the degree of the electrostatic
shielding at different salt concentrations and can be explored
by EXAFS spectra analysis.
Here, we present the combined multiple data (MD) mul-
tiple scattering (MS) EXAFS at 16–20K and density func-
tional theory (DFT) analysis of the truncated Ab116 peptide
complexed with Cu21 in solution under a range of buffer
conditions, in particular in phosphate-buffered saline (PBS)
buffer with a range of NaCl concentrations. For comparison
with the truncated Ab116, we also measured EXAFS spectra
for low concentration solutions of Cu21 complexed with the
full-length peptides Ab142M35(O) and Ab142M35V,
where Met-35 has been oxidized to methionine sulfoxide and
mutated to valine, respectively. The oxidation of Met-35
reduces aggregation of the peptide (32,33), which is impor-
tant for the solution EXAFS, whereas the M35V mutant data
should help to clarify further the role of Met-35 in copper
coordination.
MATERIALS AND METHODS
Sample preparation
All human Ab peptide samples in Table 1 except sample 4 (Ab16-PB100)
were synthesized at the University of Melbourne. Sample 4 was purchased
from Auspep Pty Ltd. (Melbourne, Australia). The Ab-Cu21 complex
samples were freshly prepared before the data collections. Known quantities
of Ab16 peptides were dissolved in phosphate buffer (1 3 PB: 10 mM
Na2HPO4, 2mM KH2PO4, and 1000 mL H2O; pH 7.4) with 0%, 50% (68.5
mM), 75% (103 mM), and 100% (137 mM) addition of NaCl. Sample 5
(Ab16-PBS) of Ab16 was dissolved in common isotonic PBS buffer. For
comparison, samples of the full-length peptide Ab142 with M35(O) and
M35V modiﬁcations and complexed with Cu21 were also prepared and
analyzed. Both samples were synthesized as described previously (32,34)
and dissolved in 0.05 M ammonia before isotonic PBS buffer was added.
Freshly prepared solution of CuCl2 was added to peptide solutions to the
concentration ratio 1:1 of metal/peptide. Finally, glycerol (21% for samples
1–4 and 24% for samples 5–7 in Table 1) was added to the sample solution as
a cryoprotectant. Glycerol is an accepted cryoprotectant in protein crystal-
lography and in EPR and EXAFS spectroscopy. It has been shown that in-
clusion of glycerol up to 50% does not affect EPR properties of Cu21 bound
to Ab (8,17). Immediately after preparation, the samples were injected into
230mLTeﬂon (DuPont,Wilmington, Delaware) cells made with twoKapton
(Goodfellow Cambridge, Cambridge, UK) windows (;4 3 25 mm) and
rapidly frozen in liquid nitrogen. Aggregation of peptide complexes in the
presence of NaCl from buffers was not observed. The truncated peptide
Ab116 does not contain the C-terminal ﬁbrillization domain, and the time
between addition of Cu21 to the peptides and freezing of the samples was not
sufﬁcient to generate a substantial concentration of b-sheets in case of the
full-length peptides Ab142 with M35(O) and M35V modiﬁcations.
X-ray absorption data collection
A series of CuK-edge (8980.4 eV) x-ray absorption spectrum scans (Table 1)
were obtained from each sample in a ﬂuorescence mode at low T using a
helium displex cryostat. The experiments were conducted at the Paciﬁc
Northwest Consortium Collaborative Access Team (PNC-CAT) 20BM
bending magnet beamline at the Advanced Photon Source (APS) of Argonne
National Laboratories, Argon, IL. The beamline optical setup was equipped
with a double crystal Si(111) monochromator and a 5 mrad rhodium-coated
harmonic-rejection mirror. To increase sensitivity with millimolar concen-
tration solutions, a 12-element liquid N2-cooled Ge detector was used. The
beam size was 1 3 15 mm (vertical 3 horizontal). The incident x-ray in-
tensity was monitored using an ionization chamber. The stability of the
monochromator energy was checked for all spectra by the simultaneous
accumulation of a Cu foil spectrum by transmittance. The energy was cali-
brated with reference to the lowest energy inﬂection point of a Cu foil
spectrum, which was assumed to be 8980.4 eV. X-radiation reduction of
Cu21 was monitored by comparing edge spectra (the x-ray absorption near-
edge structure (XANES)) for consecutive scans. Cu21 in aqueous solutions,
especially the halogen-containing salts, can be reduced by the intense x-ray
beams (35,36). After the detection of marked photoreduction of Cu21 in
sample 2 with NaCl salt (spectra scans shown in Fig. S1 in Supplementary
Material, Data S1), i.e., increasing intensity ;8984 eV and reduction of the
white-line intensity typical for Cu11 in the XANES region of the consecutive
scans, an attempt was made to collect scans by moving the sample in the
vertical direction in 150 mm steps within the cell window area. This move-
ment effectively eliminated the radiation damage of the rest of the samples
with halogen-containing buffers. The superposition of EXAFS spectra for all
samples is shown in Fig. S2 in Data S1. The spectrum of radiation-damaged
sample 2 (Ab16-PB50) deviates noticeably from the others and produced
marked changes in r space (Fourier-transformed results are not shown).
These data will not be considered in further analyses. The measurement
uncertainty ek (37) shown in Table 1 demonstrates that samples 5 (Ab16-
PBS) and 6 (Ab42M35V-PBS), and especially sample 7 (Ab42M35(O)-
PBS), are much noisier (higher ek), as is expected for the lower concentration
of the Cu21 peptide complexes. Overall, features of Ab42M35V and
Ab42M35(O) spectra are similar to those of the spectra of short peptides.
TABLE 1 Samples and experimental data
No. Sample Buffer, PB 1 NaCl% Cu/Ab, mM T, K Usable kmax, A˚
1 N scans Scan t, min ek 10
4*
1 Ab16-PB: PB 2.2 16.5 11.8 13 40 0.414
2y Ab16-PB50 PB150% 2.2 16.5 11.8 13 40 0.432
3 Ab16-PB75 PB175% 2.2 16.5 11.9 12 40 0.543
4 Ab16-PB100 PB1100% (PBS) 2.2 20K 11.7 15 40 0.589
5 Ab16-PBS PBS 1.1 20K 11.3 10 25 1.303
6 Ab42M35V PBS 0.9 20K 11.7 12 25 1.450
7z Ab42M35(O) PBS 0.85 20K 11.8 12 25 2.136
*ek is the measurement uncertainty in k-space (37).
ySample 2 was not used in the reﬁnement due to signiﬁcant radiation damage (see Data S1).
zSample 7 had high noise and was not included in the ﬁnal MD reﬁnements.
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Furthermore, the spectra in this study are similar (although less noisy) to
those of Ab1-40-Cu
21 (26) and Ab1-16-Cu
21 (27), which are reported to be in
the k range of ;3–11 A˚1. Further subtle differences between the spectra
measured in this study will be analyzed by comparison of energy-calibrated
and normalized XANES, because the XANES region is more sensitive to
small structural differences and less affected by noise.
X-ray absorption data analysis
XANES region
XANES spectra were extracted from the experimentally measured absorp-
tion coefﬁcient using background subtraction and normalization methods
implemented in the program ATHENA (38), an interface to IFEFFIT (39).
For a reliable comparison of the XANES spectra, a consistent way of nor-
malizing near-edge data has been used by matching the measured spectra to
the energy dependence of the Cromer-Liberman calculations (40) for the
absorption of a free atom at energies far below and above the edge (38). Fig.
1 A (see also Fig. S3 A in Data S1) shows the superimposed XANES regions
of normalized absorption amplitude versus energy E for six samples, as in
Table 1 (1: Ab16-PB; 3: Ab16-PB75; 4: Ab16-PB100; 5: Ab16-PBS; 6:
Ab42-M35V; and 7: Ab42-M35(O)). Although the spectra are generally
similar, they can be split in two groups: 1), three spectra for samples 1, 3, and
4 with higher concentration (;2 mM) of complexes and 2), three spectra for
samples 5, 6, and 7 with the lower concentration (;1 mM) of the Cu21
peptide complexes. Fig. 1 B shows superimposed spectra within the groups.
The noisy spectrum for sample 7 was excluded from further analysis. The
group with data 5 and 6 (Fig. 1 B, top spectra) have more pronounced
shoulders B at ;8987eV and D at 9010 eV, and slightly reduced white-line
amplitude C at 8997 eV (see also Fig. S1 A in Data S1). The similarity in the
series of 1, 3, and 4 measurements of the same system (Ab116-Cu
21) in
buffer with varying concentrations of NaCl salt suggests that the geometry of
the Cu21 coordination does not change noticeably through this series. In
contrast, the similarity of spectra in the series of 5 and 6 (and, to some extent,
noisy 7) measurements of different systems including the short peptide
Ab116-Cu
21 and the full-length peptide Ab142M35V-Cu
21 (or
Ab142M35(O)-Cu
21) complexes suggests that the Cu21 coordination also
does not change signiﬁcantly through this series and that the Met-35 modi-
ﬁcations do not have a noticeable effect on the Cu21 environment. The
samples 5–7 from one group are in PBS buffer, which is effectively PB with
100% NaCl buffer used for the sample 4 from the other group. The only
signiﬁcant difference in the preparation of these two groups of samples is the
concentration of the complex in solution. The concentration of the 1, 3, and 4
complexes was twice as high compared to that of the 5–7 complexes. The
observed, subtle XANES changes between the two groups of data in Fig. 1 A
must be primarily due to the Ab-Cu21 concentration in solution.
EXAFS region
The EXAFS oscillations x(k) were extracted from the experimentally mea-
sured absorption coefﬁcient using an automated background subtraction
AUTOBK algorithm (41) implemented in the program ATHENA (38). The
EXAFS oscillations x(k) were quantitatively analyzed by the ARTEMIS (38)
program, also an interface to IFEFFIT (39), using ab initio theoretical am-
plitude, phase, and mean-free path factors calculated by FEFF6 (42). Con-
strained and restrained reﬁnement procedures were used to minimize the
number of free parameters in the least-squares reﬁnement to increase the
degree of determinacy of the model and to keep the geometry of ligands
(amino acids) close to those of stereochemically acceptable conformations.
The metal ligands in this study were treated as idealized rigid bodies and
included atoms of selected amino acids at the distance #5 A˚ from the metal
atom (43). The parameters used to construct these units were taken from the
averaged bond distances and angles of crystallographically characterized
polypeptide structures (44). The geometry of the ligands was kept restrained
within standard uncertainties given for bond lengths and angles, and its po-
sition relative to the metal atom was deﬁned by the position of the ﬁrst shell
nitrogen/oxygen atom ri and the two angular parameters fi and ui (45). To
further reduce the number of reﬁned parameters, the values of the Debye-
Waller factors (s2) for the ligand (treated as rigid bodies), which represent the
root mean-square variation in ri due to both static and thermal disorder, were
initially assigned the same value as for the ﬁrst-shell atoms. At the ﬁnal stages
of reﬁnement, however, the displacement terms for higher shells of peptide
atoms (at the second shell 2.3 A˚, r, 4.0 A˚ and at the third shell r. 4.0 A˚)
were multiplied by estimated and ﬁxed coefﬁcients A2 and A3 (s
2 (second
shell) ¼ A2 s2 (ﬁrst shell reﬁned) and s2 (third shell) ¼ A3 s2 (ﬁrst shell re-
ﬁned)) to reﬂect the increase of the displacement termswith the distance to the
absorber (Cu). The structural parameters reﬁned during constrained/re-
strained reﬁnements included 1), the distances ri of the histidine groups (that
is, the Cu-N bond) and the other low-Z ligands (for example, Cu-O bonds), 2),
the angular parameters associated with the ligands, and 3), the Debye-Waller
factors s2i for each ligand. The coordination number Ni of the shell for each
type of neighboring atom was kept ﬁxed. In addition to the structural pa-
rameters, the photoelectron energy threshold (Fermi energyDE0 shift), which
was treated as a single overall parameter for the multiple shell ﬁts, was varied
to correct for the simple estimate of E0 made in ATHENA. The amplitude
reduction factor (core-hole factor) S20 was allowed to be adjusted around the
starting value of S20 ¼ 0:9 for Cu, which is accurate to within a few percent for
copper compounds (46). The ﬁtting procedure consisted of successive cycles
of constrained reﬁnement followed by restrained reﬁnement. TheCux(k) data
were weighted by k3 and windowed between 0 , k , kmax A˚
1 using a
Kaiser-Bessel windowwith dk¼ 2.0 A˚1 to minimize spectral ringing. In the
course of reﬁnement, the multiple reﬁnements of k weights (simultaneous
reﬁnements with k1, k2, and k3, or their combinations) were also used. Dif-
ferent values of k weight emphasize different regions of the spectrum, re-
ducing correlations between parameters. The ﬁts were carried out on both the
FIGURE 1 The XANES regions of normalized
absorption amplitude versus energy E for (A) six
samples as in Table 1 (1) Ab16-PB, (3) Ab16-
PB75, (4) Ab16-PB100, (5) Ab16-PBS, (6) Ab42-
M35V, and (7) Ab42-M35Ox) and (B) two groups
of superimposed according to similarity spectra for
samples 1 (solid line), 3 (dashed line), and 4 (dotted
line) in the lower group and for samples 5 (solid
line) and 6 (dashed line) in the upper group. The
noisy spectrum for sample 7 is not shown. Spectral
features at 8979, 8987, 8997, 9005, 9010, and 9045
eV are marked as A, B, C, D, E, and F, respectively.
For clarity, the spectra are stacked with offset (A)
0.2 and (B) 0.5 units along the vertical axes.
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real and imaginary parts of x(r) in the region of 0, r, 5.0 A˚ using a Kaiser-
Bessel window with dr ¼ 0.2 A˚. After reﬁnement of the model with single
scattering (SS) contributions from all atoms#5 A˚ from the Cu metal, all MS
contributions .10% and l # 4 (triple scattering paths with four legs) were
analyzed and included in the reﬁned model.
The determinacy of a reﬁnement can be further improved by increasing the
number of datapoints per ﬁtted parameter. Having two groups ofmeasurements
((1, 3, and 4) and (5 and6)) inTable 1with different concentrations ofAb-Cu21
complexes and observing that theXANES and EXAFS spectra (Fig. 1; see Fig.
S2 in Data S1), and therefore the geometry of the Cu21 coordination, did not
change signiﬁcantly within groups, we have attempted an MD reﬁnement for
each group. The MD reﬁnement is similar to protein crystallographic structure
determination using diffraction measurements from multiple crystals. In this
case, each of the global models that are deﬁned below was used to simulta-
neouslyﬁt all data sets in eachgroupofmeasurements.All structural parameters
and S20 values remained the same throughout the sequence, andDE0was reﬁned
for each data set separately. Best-ﬁt parameters for models of Ab-Cu21 com-
plexes are shown in Table 2 and in the Data S1.
Ab-Cu21 starting models
The initial ﬁttings of the XAFS data with the ﬁrst shell SS theory including
nitrogen and/or oxygen atoms around copper showed that the coordination
number ofCu21 is six.This suggests that theCu21 can be potentiallyoctahedral
coordinated with three histidines, oxygen(s) donating amino acids, and one or
twowater molecules. It should be noted that, because the Cu-O and Cu-N bond
distances and backscattering amplitudes are somewhat similar, it is difﬁcult to
distinguish between their respective contributions in the EXAFS spectra.
Considering themost probable coordination ofCu21 to Ab via three histidines,
aspartic or/and glutamic acid, and waters, we constructed a six-coordinated
model (Model 1), which includes the equatorial imidazole rings of His-6, His-
13, His-14, the carboxylate side chain of Glu-11 or Asp-1, and one axial water.
Because of the similar nature of the side-chain electron donor of Asp and Glu,
these two amino acid residues can be considered as equivalent. Within ;5 A˚
from the central Cu atom, the geometry of the Glu side chain (Cb, Cg, Cd, Oe1,
and Oe2) is virtually identical to the Asp side chain, including the backbone
carbons (Ca, Cb, Cg, Od1, and Od2), and cannot be easily distinguished by the
EXAFS spectra measurements. For comparison, we also constructed a six-
coordinatedmodel (Model 2), which includes the equatorial imidazole rings of
His-6, His-13, His-14, the phenol ring of Tyr10, and two axial waters. DFT
calculations were then used to comparatively explore the ground state elec-
tronic structures for thesemodels, and theDFToptimized geometrieswere used
as the starting models in EXAFS spectra ﬁtting.
DFT investigation of starting models
DFT calculations were carried out in the gas phase using the B3LYP func-
tional set (47) and the LANL2DZ basis set (48) for appropriate model systems
with the Gaussian 03 suite of programs (49). The suitability of calculations at
this level of theory, functional, and basis set were conﬁrmed by computing the
optimized geometry of trans-bis(L-alaninato-N,O)-copper(ii) (50), for which a
high-resolution crystal structure is available in the Cambridge Structural Da-
tabase (id: CUALTE01). The optimized geometry for trans-bis(L-alaninato-
N,O)-copper(ii) was square planar and showed very good agreement with the
experimental structure with Cu-O bond distances of 1.91 A˚ and 1.92 A˚ (1.95 A˚
in the crystal structure), Cu-N bond distances of 2.03 A˚ and 2.04 A˚ (1.98 A˚ in
the crystal structure), and the N-Cu-O bond angle of 95.0 (93.8 in the crystal
structure). The deviations in bond lengths from the experimental values are of
the same order observed previously for Cu containing small molecules (51).
Next, Cu21 bound to Abwasmodeled by a Cu atom centrally coordinated
to three imidazole rings and a carboxylate side chain (Asp or Glu) (Model 1)
or a tyrosinate (Model 2) at equatorial positions, and one (Model 1) or two
(Model 2) water molecules at axial positions. The model system had a total
charge of one and a spin multiplicity of two. In all geometry optimizations,
the modiﬁed GDIIS (52) algorithm and tight convergence criteria were used.
Stationary points were checked for true energy minima by performing fre-
quency calculations. Setup of input ﬁles and visualization of results was
carried out with GaussView v.3.09 (53).
RESULTS AND DISCUSSIONS
Quantum mechanical calculations
The DFT-optimized geometries for Cu21 bound to gluta-
mate/aspartate, three imidazoles, and one water molecule
(Model 1) and to tyrosinate, three imidazoles, and two water
TABLE 2 Best-ﬁt EXAFS and DFT parameters of Model 1 for
Ab-Cu21 complexes
Model 1 ‘‘Asp-1/Glu-11’’ multiple EXAFS data ﬁts DFT
Samples 1, 3, 4 5, 6
S20 0.95 (0.03) 0.92 (0.04)
DE0
Sample 1 0.7 (0.5)
Sample 3 0.8 (0.5)
Sample 4 0.6 (0.5)
Sample 5 0.2 (0.7)
Sample 6 0.3 (0.7)
r1 (His-6) 1.981 (0.008) 1.99 (0.02) 2.03
r2 (His-13) 1.908 (0.007) 1.94 (0.02) 2.03
r3 (His-14) 2.08 (0.01) 2.06 (0.02) 2.07
r4 (O1 carboxylate) 1.941 (0.007) 1.94 (0.01) 2.02
r5 (w1) 2.03 (0.01) 2.04 (0.02) 2.30
r6 (O2 carboxylate)* 2.27 (0.01) 2.26 (0.01) 2.63
r7 (‘‘solvent’’) 4.45 (0.01) 4.46 (0.01)
f1 (His-6) 3.2 (1.0) 0.4 (1.7) 6.4
f2 (His-13) 1.6 (8.6) 1.8 (10.0) 6.4
f3 (His-14) 4.7 (1.0) 6.4 (2.8) 17.4
f4 (carboxylate)
y 96.5 (0.2) 95.9 (0.4) 104.0
s2 (1st shell) 0.0020 (0.0005) 0.003 (0.001)
s2 (2nd shell)z 0.006 (0.008) 0.003 (0.001)
s2 (3rd shell) z 0.008 (0.001) 0.009 (0.002)
s2 (‘‘solvent’’) 0.005 (0.002) 0.003 (0.002)
Nind 111 72
Nvar 16 15
x2 4.108 1.406
Rall
§ 0.0134 0.0277
R1 0.0097
R3 0.0185
R4 0.0121
R5 0.0244
R6 0.0310
DEo is the edge position relative to the photoelectron energy threshold Eo
for samples: 1:- 8992.4; 3: 8992.2; 4: 8991.9; 5: 8992.7; and 6: 8992.4 eV;
ri and fi refer to the distances (in A˚) and the polar angle (in degrees) for
shell i; s2 Debye-Waller terms (in A˚2); Nind, Nvar, x
2,and R are deﬁned in
the main text or in Data S1; estimated standard deviation from least-squares
is given in parentheses.
*Calculated distance to the second Asp-1/Glu-11 carboxyl oxygen O2.
yCu-Oe1-Cd (Glu-11) or Cu-Od1-Cg (Asp-1) angles.
zDebye-Waller terms for peptide atoms at the second shell (2.3 A˚ , r ,
4.0A˚) and at the third shell (r . 4.0 A˚), respectively, adjusted by the
estimated coefﬁcients A2 and A3: s
2 (second shell) ¼ A2 s2 (ﬁrst shell) and
s2 (third shell) ¼ A3 s2 (ﬁrst shell).
§All R factors are calculated in r-space, and Rn values are partial factors for
MD sets used in reﬁnements.
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molecules (Model 2) are shown in Table 2 and Table S2 in
Data S1, respectively. Both optimized structures (see Fig. 3 A
and Fig. S5 A in Data S1) are of Jahn-Teller-type distorted
octahedral coordination about the copper ion, with the axial
ligands being twowaters placed asymmetrically (at elongated
distances of 2.41 A˚ and 2.78 A˚ from the Cu21 ion) in the case
of Model 2. The more distal water is potentially hydrogen
bonded to the tyrosinate oxygen, which is 2.00 A˚ from the
Cu21 ion. In the case of the carboxylate system (Model 1),
the axial ligands are a water molecule at a distance of 2.30 A˚
from Cu21 ion, and one of the carboxylate oxygen atoms at
2.63 A˚ distant from the Cu21 ion. The other carboxylate
oxygen (2.02 A˚) and the three imidazole nitrogen atoms
(2.03–2.07 A˚) are in an approximately planar arrangement
about the Cu ion. The DFT-optimized geometries for Model
1 and Model 2 were used in the EXAFS spectra data re-
ﬁnements as described below.
X-ray absorption analysis
XANES region
Fig. 1 A shows the XANES regions of Ab-Cu21 spectra for
all samples from Table 1, except for sample 2 (Ab16-PB50),
which showed signiﬁcant x-radiation damage. Fig. 1 B shows
a similarity between XANES spectra within the two groups,
which mainly differ in the concentration of the peptide
complex in solution. The measurement uncertainty ek shown
in Table 1 demonstrates that sample 7 (Ab42-M35Ox)
spectra is much noisier than all the others (highest ek), and it
was not included in Fig. 1 B. The series of 5, 6, and 7 samples
has effectively doubled the content of salt (NaCl) per mole-
cule of the Ab-Cu21 complex in solution compared to the
series of 1, 3, and 4 samples. This relative salt increase may
create a different hydration and salt/peptide interaction effect
on the geometry of the metal binding site. At higher con-
centrations of salt, the Cl anions readily form ion pairs with
nitrogen-based (cationic) peptide side chains, and they are
known to adsorb to nonpolar surfaces or portions of Arg, His,
and Lys side chains (54). The most interesting features that
show differences or similarities between the two groups of
measurements are ; 8979, 8987, 8997, 9005, 9010, and
9045 eV. These features are marked as A, B, C, D, E, and
F, respectively, in Fig. 1 A and are enlarged in Fig. S3 in
Data S1.
A systematic study (55) of 19 Cu11 and 40 Cu21 com-
plexes showed that the intensity and position of near-edge
features are strongly correlated with the oxidation state and
the coordination mode. Our recent XANES study (56) of
Ab116 in complex with Cu
11 and Cu21 is in good agree-
ment with these previous studies. The Ab-Cu21 complexes
have very weak peaks at;8979 eV (labeled A in Fig. 1 B; see
also Fig. S3B in Data S1), which were assigned as originating
from 1s/3d quadrupolar-allowed transitions in the Cu21
species (55,57). It was shown (57) that the features fromB toF
(Fig. 1 B) depend on the geometric details of the Cu21 coor-
dination environment. The small shoulder at;8987–8988 eV
(labeled B in Fig. 1 B), which stems from either a vibronically
allowed 1s/4s transition or 1s/4p transitions with ametal-
ligand charge-transfer shakedown, has been assigned pri-
marily to scattering by the axial ligands, and its intensity and
position has been related to the number and position of these
ligands (57). Such low-energy, rising-edge features can also
be due to single-electron scattering from distant (solvent)
atoms (58). The B peak shown in Fig. 1B is shifted to 8987eV
and is more pronounced for the lower-concentration 5 and
6 peptide complexes relative to that at 8988 eV for the 1, 2, or
4 higher-concentration peptide complexes (see also Fig. S3 C
in Data S1). This shift may reﬂect an increased contribution
from the distant Cl axial ligands to theCu21 environment for
the 5 and 6 samples. The features marked C and D at 8997–
9005 eV in Fig. 1 B were assigned to the main 1s/4p (or
1s/continuum) transition. The reduction of the main peak
for the 5 and 6 measurements appear to be related to the in-
creased contribution of distant ligands, such as the secondary
shell axial solvents (H2O and/or Cl
) (58). The differences in
amplitudes at 8985–9005 eV observed in CuBr2 solutions
(59) with either an equal or higher relative concentration of
NaBr were attributed to the association of the Br and Cu21
ions at the higher concentration of NaBr. There are other
important features at E and F in the XANES region of Cu21
spectra, which are represented by shoulders at 9010 and 9045
eV, respectively, in Fig. 1 B (see also Fig. S3 D in Data S1).
These features do not change noticeably across the series of
measurements andwere assigned as being due toMS from the
ﬁrst shell ligands in theCu21 species (55,59); they depend, for
example, on the orientation of the imidazole ringswith respect
to the CuN4 plane in Cu
21 imidazole complexes (57). This
ﬁnding suggests that the Cu21 species has similar imidazole
environment in all peptides studied here.
EXAFS region
Figs. 2, B and D, show the EXAFS regions of Ab-Cu21
spectra (dashed lines) for two groups of samples from Table
1, except for sample 2 (Ab16-PB50), which showed signif-
icant x-radiation damage, and sample 7 (Ab42-M35Ox),
which had a high level of noise. The similarity in the XANES
and EXAFS regions within the two groups of measurements
((1, 3, and 4) and (5 and 6)) suggests that geometry of the
Cu21 coordination does not change signiﬁcantly across the
samples within the groups. Therefore, we attempted an MD
EXAFS reﬁnement in each group of measurements. Each of
the two DFT-optimized global models was used to simulta-
neously ﬁt the experimental information extracted from the
EXAFS regions of Ab-Cu21 spectra of the 1, 3, and 4 and
then of the 5 and 6 MD sets. All structural parameters and
S20 values remained the same throughout each group of data,
andDE0 was reﬁned for each data set separately. The data sets
were weighted by the measurement uncertainties ek (Table 1).
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After the thorough MS MD reﬁnement of the DFT-opti-
mized Model 1, further signiﬁcant improvement of the ﬁtting
of the 1, 3 and 4 MD were achieved with the addition of the
SS contribution from oxygen atoms (or atoms with occu-
pancy 2) at the distance of 4.4 A˚. With two additional reﬁned
parameters, the R-factor and x2 decreased from 2.01% to
1.34% and from 5.980 to 4.108, respectively (Table 2). The
signiﬁcance of this improvement is supported by the F-test
(see Data S1), which shows that the calculated F2,95 ¼
21.646 is seven times the tabulated values of F-distribution,
F2,95,0.05 ¼ 3.092, at the common signiﬁcance level of a ¼
5%. This ﬁnding justiﬁed adding two oxygen atoms to the
reﬁned Model 1 for the 1, 3, and 4 MD ﬁt. These oxygen
atoms are called solvent in Table 2. We can hypothesize that
these two oxygen atoms may belong to the carboxylate group
from the N-terminal amino acids, such as Asp-1, which may
participate in hydrogen bonding with axial water W1 to
stabilize the Cu binding site. This observation is consistent
with a recent electron paramagnetic resonance spectroscopic
analysis (19), where it was proposed that Asp-1 can be in-
volved in metal binding through hydrogen bonding interac-
tions and not via direct equatorial ligation to Cu21. In this
model, the direct coordination of Cu21 is made by three
histidines (His-6, His-13, and His-14), glutamic acid (Glu-
11), and axial water, which is involved in hydrogen bonding
with the Asp-1 carboxylate.
In the 5 and 6 MD reﬁnement, the Debye-Waller factors
for the two solvent oxygen atoms were reﬁned to very low
values, suggesting that the coordination number of solvent
should be increased or heavier solvent ions should be in-
cluded. Best ﬁts were obtained with either four oxygen or
three chlorine atoms at approximately the same distance of
4.5 A˚ from the central Cu21 ion. Given the XANES analysis
described above, it is reasonable to suppose that, at the higher
content of NaCl per molecule of complex in solution, the Cl
anions can interact with the nonpolar portions of His side
chains (54) and/or replace oxygen atoms from water or Asp-1
modeled at ;4.4 A˚ in the 1, 3, and 4 MD reﬁnement. For
example, it was reported that a Cl replaced the Asp car-
boxylate when the Asp of an Asp-Arg salt link in a phos-
phate-binding protein was mutated to a Gly or Thr (60). The
ﬁnal reﬁnement in Table 2 for samples 5 and 6 included three
chlorine atoms at the same distance. The signiﬁcance of this
model improvement is supported by the F-test. With two
additional reﬁned parameters, the R-factor and x2 decreased
from 5.980 to 4.108 and from 2.191 to 1.406, respectively
(Table 2). The calculated F2,57 ¼ 15.912 is ﬁve times the
tabulated values of F-distribution, F2,57,0.05 ¼ 3.158, re-
spectively, at the signiﬁcance level ofa¼ 5%. The best ﬁts of
the Model 1 to the EXAFS MD sets are shown in Fig. 2. Fig.
2, B and D, show the k3-weighted x(k) data within the usable
k range #12 A˚1 (Table 1). Figs. 1, A and C, show the x(R)
results or the magnitude of the Fourier-transformed x(k) data.
The solid lines represent the theoretical ﬁts to the experiment
data, and values for ﬁtted parameters are shown in Table 2.
The best ﬁts obtained with the Cu21 coordination number
of six were also supported by the values of the amplitude
reduction factor S20; which strongly correlates with the co-
ordination number of the model. The S20 values in Table 2 are
within a standard deviation from that expected for the Cu
atom (46). The reﬁnement of the ﬁve-coordinate model with
the omission of w1 (Table 2) produced unphysical S20 ;1.5
and signiﬁcantly higher R factors. The Debye-Waller pa-
rameters in Table 2 are in agreement with the values obtained
by x-ray absorption for other Cu21-imidazole systems (43)
and those obtained by ab initio calculations for Zn21-imid-
azole systems (61,62). The geometries of the ligands were
kept restrained within standard uncertainties given for bond
lengths and angles and their positions relative to the metal
ion, as deﬁned by the positions of the ﬁrst shell nitrogen/
oxygen atom ri and the two angular parametersfi and ui. The
ui angles contributed insigniﬁcantly to the reﬁnements and
were ﬁxed at zero. The EXAFS angles fi and distances ri for
histidine residues in Table 2 suggest that these ligands are
somewhat rotated within the plane of imidazole rings and that
they tend to be close to the Cu21 ion compared to the DFT-
optimized parameters in vacuo for side chains of selected
residues unrestricted by the peptide backbone.
The structural geometry for Model 1 based on the MD
reﬁnement of the 1, 3, and 4 data sets is shown in Fig. 3 B.
The distorted six-coordinated Cu21 environment can be
viewed as a dissymmetric square pyramidal arrangement.
This geometry includes an axially elongated square pyramid
formed by three imidazole nitrogen atoms at 1.91–2.06 A˚ and
one carboxylate oxygen atom at 1.94 A˚ in the near equatorial
plane and an axially localized second carboxylate oxygen
atom at 2.27 A˚. The water molecule is transverse-axially
localized at a short distance of 2.04 A˚, and the second shell of
solvent atoms is at 4.5 A˚. The structural geometry does not
contradict the XANES features discussed above, even though
this structure is at variance with the generally expected Jahn-
Teller distortion octahedral model, which was suggested by
DFT optimization with two axial oxygen atoms at longer
distances. It should be noted that the DFT optimization did
not include the second shell effects from the peptide back-
bone, potentially hydrogen bonded ligands, and distant sol-
vent atoms. The Jahn-Teller distortion in Cu21 complexes is
a dynamic process (63), which suggests that the geometry of
Ab-Cu21 complexes should be somewhat plastic (64). The
obtained structure in solution is in accordance with the re-
cently proposed dynamical view based in particular on XAS,
where different six-, ﬁve-, and four-coordinated structures
can coexist and exchange among themselves in solutions of
Cu21 aqueous complexes, and the classical view of the Jahn-
Teller distortion is no longer supported (65,66). The observed
distorted Cu21 environment can be related to the Ab peptide
multifunctional properties including chelating Cu, Zn, and Fe
metals with a relatively high afﬁnity.
The EXAFS distances shown in Table 2 are slightly greater
than those obtained from the Ab1-40-Cu
21 (26) and Ab1-16-
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Cu21 (27) EXAFS for pentacoordinated Cu21 with three
nitrogen atoms at 1.85–1.95 A˚ from the same three histidines
(His-6, His-13, and His-14) and two oxygen atoms, one at
2.00–2.06 A˚ from Tyr-10 and the other one at 1.91–1.95 A˚
from either a water molecule or from some other amino acid
residue. It should be noted that the position of the potential
water molecule is even closer to the Cu21 ion than the water
localization (2.04 A˚) in our model. Despite the different Cu21
coordination model suggested in other studies (26,27), the
EXAFS spectra for Ab1-16-Cu
21 and Ab1-40-Cu
21 are sim-
ilar to those presented here. However, the statistical signiﬁ-
cance of the simulations, that is, the R factors ¼ 28–32%
(even though they were calculated in k-space including high-
frequency noise components) (26,27), and the overall de-
terminacy of the reﬁnement (ratio of independent datapoints
to the number of reﬁned parameters of 17/9 (26)) may indi-
cate a somewhat limited accuracy of the proposed model
involving tyrosine. In addition, the lack of a proper alignment
of the theory to the measured EXAFS spectra (the energy
shift parameter DE0 ;10 eV (27)) may result in erroneous
minima in the reﬁnement (67).
For comparison with the reﬁned Model 1 (Table 2), we
also ﬁtted the DFT-optimizedModel 2, which includes Tyr10
residue, to the same EXAFS data sets (see Table S1 and Fig.
S5 B in Data S1). The structures also had a distorted six-
coordinated copper ion with three imidazole nitrogen atoms
(1.91–2.10 A˚) and one tyrosinate (1.94–1.97 A˚) oxygen atom
in an approximately equatorial arrangement. The axial li-
gands are two water molecules placed asymmetrically at the
distances 1.99–2.04 and 2.26–2.32 A˚, again shorter than
expected for the Jahn-Teller distorted octahedral coordina-
tion from the DFT-optimized model (see Table S1 in Data
S1). The additional solvent atoms at 4.4 A˚ were also included
in the reﬁnement ofModel 2. AlthoughModel 2 has one extra
parameter, its reﬁnement resulted in higher values of R fac-
tors (1.92% (data 1, 3, and 4) and 3.35% (data 5 and 6)) and
x2 (5.790 (data 1, 3, and 4) and 1.748 (data 5 and 6)) (see
Table S1 in Data S1) than those for Model 1 (Table 2). The
calculated statistical F-test value of F1,94 ¼ 27.307 for 1, 2
and 4 MD ﬁt is four times greater than the tabulated value of
F-distribution (F1,94,0.05¼ 3.940) at the common signiﬁcance
level of a ¼ 5%, whereas the F-test value of F1,56 ¼ 10.956
for 5 and 6 MD ﬁt is 2.7 times greater than the tabulated
F1,56,0.05 ¼ 4.010 at the same signiﬁcant level of a ¼ 5% or
four times greater of tabulated F1,56,0.1 ¼ 2.739 at the sig-
niﬁcance level of a¼ 10% (see Data S1). In other words, the
chances that random errors in the obtained data would cause
Model 2 (Tyr-10) to ﬁt better are zero for the 1, 3, and 4 MD
and ;0.1% in the case of the lower concentration of Cu21
peptide complexes and noisier 5 and 6 MD. All these factors
FIGURE 2 Model 1 (Asp-1/Glu-11 carboxylate)
best ﬁts of (B and D) the Cu K-edge k3-weighted
EXAFS and (A and C) the corresponding Fourier-
transformed data for ﬁve Ab-Cu21 samples used in
two separate MD reﬁnements: (A and B) for samples
(1) Ab16-PB, (3) Ab16-PB75, and (4) Ab16-
PB100, and (C and D) for samples (5) Ab16-PBS
and (6) Ab42M35V-PBS. The solid lines are the
theory; the dashed lines correspond to experimental
data. The spectra are stacked with offset of (A) 2.5,
(B) 5, (C) 2, and (D) 10 units along the vertical axes.
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indicate that Model 1 is signiﬁcantly better than Model 2. In
addition, Model 1 is consistent with strong evidence that
tyrosine (Tyr10) is not the oxygen atom donor in the Ab-
Cu21 complex (7,8,11,18,19) and the observation that it is a
rare ligand in other copper-proteins (28).
CONCLUSIONS
We studied the coordination environment of the Ab116-Cu
21
complex by using low-temperature (16–20K)MDsets andMS
XAS analysis in a range of Ab-Cu21 complex solutions. We
attempted to address the problems related to the XAS analysis
of diluted biologic samples (46), such as lowphoton counts and
high noise at high k values, limited useful k range, and sensi-
tivity to the ﬁrst few coordination shells (;5 A˚ from the Cu
atom) due to the low (millimolar) concentration of the soluble
Ab-Cu21 in solution and relatively weak scattering centers (C,
N, andO).The reliability of theMSﬁttingprocedure inEXAFS
region analysis was improved by restrained reﬁnements of the
DFT-optimized models and by simultaneously ﬁtting MD sets
measured at low temperatures. The XANES investigation al-
lowed the reﬁnements of theMD sets to be justiﬁed. The Cu21
reduction by the Ab peptide was not detected, except at high
doses of x-radiation as in the case of sample 2. This ﬁnding
is consistent with recent cyclic voltammetry measurements
showing that the oxidation state of Cu is 12 for all of the
complexes Ab116, Ab128, and Ab142 (9,16). The buffer
salt (NaCl) concentration did not signiﬁcantly affect the pri-
mary copper binding mode and did not promote the Ab-Cu21
complex association in the cases of shortAb116 peptide. In the
case of relatively low (1 mM) concentration of the peptide
complex in PBS buffer, the secondary coordination sphere
involving ether solvents or hydrogen bonded N-terminal resi-
due (for example, Asp-1) was altered by the chaotropic Cl
anions. Neither the additional histidine-bridged Cu21 ion nor
signiﬁcant distortions of the ﬁrst Cu21 ion environment by
bridged histidine (as may be expected for dimeric species
(20,29)) were observed. However, dimerization can be a spe-
ciﬁc concentration-dependent phenomenon, and the tendency
for the full-length Ab142 peptides to form aggregates may
facilitate cross-linking under induced redox chemistry. The
structure of the high-afﬁnity Cu21 binding site is consistent
with the hypothesis that the redox activity of the metal ion
bound to Ab can lead to the formation of dityrosine-linked
dimers found in AD (68). It is likely that soluble Ab1–42 ini-
tially forms a 1:1 complex with Cu21, as is seen for shorter
Ab116 forms (16). Similar x-ray absorption spectra were
observed for the Cu21 complexed with full-length
(Ab142M35(O) and Ab142M35V), truncated (Ab116)
peptides, and independently measured (however differently
interpreted) spectra for Ab116-Cu
21 and Ab140-Cu
21
(26,27). The oxidized form of Met-35(O) does not provide the
oxygen ligand, even though this residue appears to be related to
the Ab toxicity and the ROS production (32).
Contrary to the report of a pentacoordinated structure with
Tyr-10 involved (26,27),we found that, under the conditions of
our experiments, the preferred Cu21 binding site in Ab is a
distorted six-coordinated (dissymmetric square pyramidal ar-
rangement) with three histidine (His-6, His-13 and His-14)
residues and a carboxylate oxygen (from either Glu-11 or
Asp-1 residue) in an approximately equatorial planar arrange-
ment, with the axial ligands consisting of a water molecule and
the other carboxylate oxygen also from Glu-11 or Asp-1. It is
also possible that that the carboxylate side chain of N-terminal
Asp-1 participates in hydrogen bonding via the axial water
molecule to stabilize the Cu21 binding site and Glu-11 coor-
dinates directly the Cu21 ion along with three histidines. This
N-terminus involvement, however, can be compromised by the
Cl anions in high-salt buffers. Thewater involvement inCu21
coordination supports the view that hydration is important in
metal binding to theAb peptide and that copper binding causes
less dehydration of the Ab peptide compared to zinc (69). The
participation of the Ab N-terminus in Cu21 coordination also
suggests that the pyro-Glu-3 Ab found in AD plaques (68)
should have a different mode of copper binding.
The novel distorted six-coordination mode (3N3O) in-
cluding three histidines, glutamic or/and aspartic acid, and
water obtained from these EXAFS studies reﬂects the plas-
ticity of the Cu21 environment in complex with the multi-
functional Ab peptide, which binds Cu, Zn, and Fe metals
with a relatively high afﬁnity.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at www.biophysj.org.
FIGURE 3 A ball-and-stick representation of the Model 1 (carboxylate
side chain from Asp-1 or Glu-11) from (A) DFT optimization and (B) MD
EXAFS reﬁnement of 1, 3, and 4 data sets. The axial oxygen atom is labeled
as water W1. The two additional solvent oxygen (Osol) atoms in (B) may
belong to the carboxylate group from the N-terminal amino acids such as
Asp-1, which may participate in a hydrogen bonding with axial water W1 to
stabilize the Cu binding site. Parts of the EXAFS structure (B) not included
in the reﬁnement are transparent.
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